Effect of GLP-1 Receptor Activation on Offspring Kidney Health in a Rat Model of Maternal Obesity

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Glastras, Sarah J ^a,b   Chen, Hui ^c   McGrath, Rachel T ^b   Zaky, Amgad A ^a   Gill, Anthony J ^b   Pollock, Carol A ^a   Saad, Sonia ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; GLP1R PROTEIN, RAT; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; PEPTIDE; VENOM;

ADVERSE EFFECTS; ANIMAL; BODY WEIGHT; CHEMICALLY INDUCED; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; FEMALE; HUMAN; IMMUNOLOGY; KIDNEY; KIDNEY DISEASES; LIPID DIET; MATERNAL NUTRITION; METABOLISM; NEWBORN; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREGNANCY; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME; WEANING;

ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FEMALE; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR; HUMANS; KIDNEY; KIDNEY DISEASES; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; OBESITY; OXIDATIVE STRESS; PEPTIDES; PREGNANCY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME; VENOMS; WEANING;

EID: 84962320642     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23525     Document Type: Article

References (33)

1. Strazzullo, P. et al. Excess body weight and incidence of stroke: Meta-analysis of prospective studies with 2 million participants. Stroke 41, e418-426, doi: 10.1161/STROKEAHA.109.576967 (2010).
2. Bogers, R. P. et al. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: A meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med 167, 1720-1728, doi: 10.1001/archinte.167.16.1720 (2007).
3. McClellan, W. M. & Plantinga, L. C. A public health perspective on CKD and obesity. Nephrol Dial Transplant 28 Suppl 4, iv37-42, doi: 10.1093/ndt/gft030 (2013).
4. MacLaughlin, H. L., Hall, W. L., Sanders, T. A. & Macdougall, I. C. Risk for chronic kidney disease increases with obesity: Health Survey for England 2010. Public Health Nutr, 1-6, doi: 10.1017/s1368980015000488 (2015).
5. Kanasaki, K., Kitada, M., Kanasaki, M. & Koya, D. The biological consequence of obesity on the kidney. Nephrol Dial Transplant 28 Suppl 4, iv1-7, doi: 10.1093/ndt/gft098 (2013).
6. Jiang, T. et al. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J Biol Chem 280, 32317-32325, doi: 10.1074/jbc.M500801200 (2005).
7. Hall, M. E. et al. Obesity, hypertension, and chronic kidney disease. Int J Nephrol Renovasc Dis 7, 75-88, doi: 10.2147/IJNRD.S39739 (2014).
8. Stemmer, K. et al. High-fat-diet-induced obesity causes an inflammatory and tumor-promoting microenvironment in the rat kidney. Disease Model Mech 5, 627-635, doi: 10.1242/dmm.009407 (2012).
9. Mathew, A. V., Okada, S. & Sharma, K. Obesity related kidney disease. Curr Diabetes Rev 7, 41-49 (2011).
10. Catalano, P. M. Obesity, insulin resistance, and pregnancy outcome. Reproduction 140, 365-371, doi: 10.1530/rep-10-0088 (2010).
11. Dabelea, D. & Crume, T. Maternal environment and the transgenerational cycle of obesity and diabetes. Diabetes 60, 1849-1855, doi: 10.2337/db11-0400 (2011).
12. Reynolds, R. M. et al. Maternal obesity during pregnancy and premature mortality from cardiovascular event in adult offspring: Follow-up of 1 323 275 person years. Bmj 347, f4539, doi: 10.1136/bmj.f4539 (2013).
13. Li, M., Sloboda, D. M. & Vickers, M. H. Maternal obesity and developmental programming of metabolic disorders in offspring: Evidence from animal models. Exp Diabetes Res 2011, 592408, doi: 10.1155/2011/592408 (2011).
14. Purcell, K. et al. The effect of rate of weight loss on long-term weight management: A randomised controlled trial. Lancet Diabetes Endocrinol 2, 954-962, doi: 10.1016/S2213-8587(14)70200-1 (2014).
15. Skov, J. Effects of GLP-1 in the kidney. Rev Endocr Metab Disord 15, 197-207, doi: 10.1007/s11154-014-9287-7 (2014).
16. Chen, H. et al. Exendin-4 is effective against metabolic disorders induced by intrauterine and postnatal overnutrition in rodents. Diabetologia 57, 614-622, doi: 10.1007/s00125-013-3132-5 (2014).
17. Song, S. et al. Serum cystatin C in mouse models: A reliable and precise marker for renal function and superior to serum creatinine. Nephrol Dial Tranplant 24, 1157-1161, doi: 10.1093/ndt/gfn626 (2009).
18. Jung, U. J. & Choi, M. S. Obesity and its metabolic complications: The role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci 15, 6184-6223, doi: 10.3390/ijms15046184 (2014).
19. Duffield, J. S. Macrophages and immunologic inflammation of the kidney. Semin Nephrol 30, 234-254, doi: 10.1016/j. semnephrol.2010.03.003 (2010).
20. Lee, S. B. & Kalluri, R. Mechanistic connection between inflammation and fibrosis. Kidney Int Suppl, S22-26, doi: 10.1038/ki.2010.418 (2010).
21. Eddy, A. A. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7, 2495-2508 (1996).
22. Meng, X. M., Nikolic-Paterson, D. J. & Lan, H. Y. Inflammatory processes in renal fibrosis. Nat Rev Nephrol 10, 493-503, doi: 10.1038/nrneph.2014.114 (2014).
23. Alfaradhi, M. Z. & Ozanne, S. E. Developmental programming in response to maternal overnutrition. Front Genet 2, 27, doi: 10.3389/fgene.2011.00027 (2011).
24. Matsuzawa-Nagata, N. et al. Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism 57, 1071-1077, doi: 10.1016/j.metabol.2008.03.010 (2008).
25. Bournat, J. C. & Brown, C. W. Mitochondrial dysfunction in obesity. Curr Opin Endocrinol Diabetes Obes 17, 446-452, doi: 10.1097/MED.0b013e32833c3026 (2010).
26. Igosheva, N. et al. Maternal diet-induced obesity alters mitochondrial activity and redox status in mouse oocytes and zygotes. PLoS One 5, e10074, doi: 10.1371/journal.pone.0010074 (2010).
27. Ozbek, E. Induction of oxidative stress in kidney. Int J Nephrol 2012, 465897, doi: 10.1155/2012/465897 (2012).
28. Fujita, H. et al. The protective roles of GLP-1R signaling in diabetic nephropathy: Possible mechanism and therapeutic potential. Kidney Int 85, 579-589, doi: 10.1038/ki.2013.427 (2014).
29. Jensen, E. P. et al. Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow. Am J Physiol Renal Physiol 308, F867-877, doi: 10.1152/ajprenal.00527.2014 (2015).
30. Elmarakby, A. A. & Sullivan, J. C. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc Ther 30, 49-59, doi: 10.1111/j.1755-5922.2010.00218.x (2012).
31. Weil, E. J. et al. Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy. Kidney Int 82, 1010-1017, doi: 10.1038/ki.2012.234 (2012).
32. Silbiger, S. R. & Neugarten, J. The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 25, 515-533 (1995).
33. Zhang, J. et al. A cationic-independent mannose 6-phosphate receptor inhibitor (PXS64) ameliorates kidney fibrosis by inhibiting activation of transforming growth factor-beta1. PLoS ONE 10, e0116888, doi: 10.1371/journal.pone.0116888 (2015).